trial · primary record
N-Acetyl-L-Leucine
CACNA1A
| Phase | Phase 3 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 60 |
| Primary completion | 2028-12-01 |
| Primary endpoint | Scale for the Assessment and Rating of Ataxia |
| Registry ID | NCT07221292 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:49.127Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07221292
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.